8 results match your criteria: "INSERM Centre de Recherche Saint-Antoine[Affiliation]"

Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients.

Sci Rep

June 2022

Département de biochimie, INSERM Centre de Recherche Saint-Antoine (CRSA), Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.

The local immune-inflammatory response elicited by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is still poorly described, as well as the extent to which its characteristics may be associated with the outcome of critical Coronavirus disease 2019 (COVID-19). In this prospective monocenter study, all consecutive COVID-19 critically ill patients admitted from February to December 2020 and explored by fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) were included. Biological assays, including digital ELISA cytokine profiling and targeted eicosanoid metabolomic analysis, were performed on paired blood and BAL fluid (BALF).

View Article and Find Full Text PDF

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation.

Front Oncol

March 2022

Sorbonne Université, INSERM Centre de Recherche Saint-Antoine, UMRs 938, Service d'hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Paris, France.

View Article and Find Full Text PDF

Response to: development of a machine perfusion device for cold-to-warm machine perfusion.

HPB (Oxford)

September 2020

Sorbonne Université, INSERM Centre de Recherche Saint Antoine UMR S-938, Department of Hepatobiliary Surgery and Liver Transplantation, Hôpital Pitié-Salpêtrière, Assistance Publique- Hopitaux de Paris, France. Electronic address:

View Article and Find Full Text PDF

Cold-to-warm machine perfusion of the liver: a novel circuit for an uninterrupted combined perfusion protocol.

HPB (Oxford)

June 2020

Sorbonne Université, INSERM Centre de Recherche Saint Antoine UMR S-938, Department of Hepatobiliary Surgery and Liver Transplantation, Hôpital Pitié-Salpêtrière, Assistance Publique- Hopitaux de Paris, France. Electronic address:

Background: Ex-vivo perfusion of liver grafts is associated with promising results for the preservation of marginal grafts. Recent studies highlight the need for a combination of perfusion conditions, such as hypothermic followed by normothermic perfusion. While comprehensive machines dedicated to liver perfusion have been developed, these systems remain costly and poorly adaptable to perfusion condition switch, which requires a complete interruption of the perfusion process.

View Article and Find Full Text PDF

The Battle Within: Interactions of Bacteriophages and Bacteria in the Gastrointestinal Tract.

Cell Host Microbe

February 2019

Department of Microbiology, Institut Pasteur, F-75015 Paris, France. Electronic address:

The intestinal microbiota is intimately linked to human health. Decoding the mechanisms underlying its stability in healthy subjects should uncover causes of microbiota-associated diseases and pave the way for treatment. Bacteria and bacteriophages (phages) are the most abundant biological entities in the gastrointestinal tract, where their coexistence is dynamic and affixed.

View Article and Find Full Text PDF

The most typical expression of cystic fibrosis (CF)-related liver disease is a cholangiopathy that can progress to cirrhosis. We aimed to determine the potential impact of environmental and genetic factors on the development of CF-related cholangiopathy in mice. Cystic fibrosis transmembrane conductance regulator () mice and littermates in a congenic C57BL/6J background were fed a high medium-chain triglyceride (MCT) diet.

View Article and Find Full Text PDF

Retinoic acid (RA) and arsenic target the t(15;17)(q24;q21) PML/RARA driver of acute promyelocytic leukemia (APL), their combination now curing over 95% patients. We report exome sequencing of 64 matched samples collected from patients at initial diagnosis, during remission, and following relapse after historical combined RA-chemotherapy treatments. A first subgroup presents a high incidence of additional oncogenic mutations disrupting key epigenetic or transcriptional regulators (primarily WT1) or activating MAPK signaling at diagnosis.

View Article and Find Full Text PDF